Impact of non-compliance on the cost-effectiveness of pharmaceuticals
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
StandardStandard
Impact of non-compliance on the cost-effectiveness of pharmaceuticals. / Hughes, D.; Hughes, D.A.
2002. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.
2002. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
HarvardHarvard
Hughes, D & Hughes, DA 2002, 'Impact of non-compliance on the cost-effectiveness of pharmaceuticals', Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium, 3/01/01.
APA
Hughes, D., & Hughes, D. A. (2002). Impact of non-compliance on the cost-effectiveness of pharmaceuticals. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.
CBE
Hughes D, Hughes DA. 2002. Impact of non-compliance on the cost-effectiveness of pharmaceuticals. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.
MLA
Hughes, D. a D.A. Hughes Impact of non-compliance on the cost-effectiveness of pharmaceuticals. 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium, 03 Ion 0001, Papur, 2002.
VancouverVancouver
Hughes D, Hughes DA. Impact of non-compliance on the cost-effectiveness of pharmaceuticals. 2002. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.
Author
RIS
TY - CONF
T1 - Impact of non-compliance on the cost-effectiveness of pharmaceuticals
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2002/11/1
Y1 - 2002/11/1
M3 - Paper
T2 - 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium
Y2 - 3 January 0001
ER -